Australia: Healthcare

Health and life sciences continue to rapidly emerge as a major sector in Australia’s economy, driving innovation, medical advancement and scientific understanding. As the sector grows, however, it is increasingly exposed to scrutiny around integrity and the consequences that follow when confidence in research and quality is questioned.

Australia’s health and life sciences sector is growing rapidly, and with that growth comes a more complex web of legal exposure for the organisations that operate within it. The recent Bartier Perry panel event, Health and Life Sciences: Research Integrity Under the Microscope, explored how failures in data and research integrity translate into real-world risk.

Health and life sciences is rapidly emerging as a major sector in Australia’s economy, helping to drive innovation, advancements in medical treatments, public health and scientific understanding. However, as the sector grows, driven by unprecedent technological change, the industry faces growing risk of fraud and research misconduct, which can have far-reaching consequences for organisations, corporate reputation and public trust.

A Queensland tribunal has ruled that an anaesthetist who photographed patients and clinical records without consent and published them in a self-authored book committed professional misconduct. The case examines the boundaries of patient confidentiality in an era of accessible publishing platforms and social media, particularly in regional healthcare settings where contextual details can lead to patient identification.

In Australia, traumatic events can happen without warning, affecting every aspect of your life. Trauma cover, also called critical illness insurance, is designed to provide a financial safety net during these difficult times.

The NSW workers compensation scheme has introduced stricter guidelines for high-risk medications including opioids, benzodiazepines, and medicinal cannabis, with proposed reforms set to commence in October 2026...

Considers QCAT's recent decisions &draws out key regulatory themes for insurers, healthcare organisations & practitioners.

New regulations on cosmetic injections like Botox follow hospitalisations from botched treatments.

This article explores the key legal challenges associated with the implementation of AI in healthcare and provides practical insights for mitigating these risks.